Simin Qin1, Jintong Na1, Qun Yang1

  • 1State Key Laboratory of Targeting Oncology, National Center for International Research of Bio-targeting Therangstics, Guangxi Key Laboratory of Bio-targeting Therangstics, Collaborative Innovation Center for Targeting Tumor Diagnosis and Therapy, Guangxi Talent Highland of Major New Drugs Innovation and Development, Guangxi Medical University, Nanning 530021, China.

Molecular immunology
|March 22, 2025
PubMed
概括

树突细胞疫苗通过利用患者的免疫系统,显示出癌症免疫疗法的前景. 提高这些治疗性癌症疫苗需要克服瘤微环境和抗原选择的挑战,以改善临床效果.